CCL2 and heart failure: In this work, we investigated Tn-I, NT-proBNP, MCP-1 and Gal-3 plasma levels as predictors of recurrent cardiovascular events (acute ischemic events, heart failure and death) in patients with stable CAD and low or persistent inflammation.